Zacks Investment Research upgraded shares of Horizon Global (NYSE:HZN) from a sell rating to a hold rating in a research report report published on Thursday.
According to Zacks, “Horizon Global Corporation is a designer, manufacturer and distributor of towing, trailering, cargo management and accessory products for original equipment, aftermarket and retail customers. Horizon Global Corporation is based in Bloomfield Hills, United States. “
Get Horizon Global alerts:Several other research analysts have also issued reports on the company. Roth Capital raised Horizon Global from a neutral rating to a buy rating and upped their target price for the company from $6.00 to $13.00 in a research report on Wednesday, August 8th. ValuEngine raised Horizon Global from a sell rating to a hold rating in a research report on Tuesday, July 3rd. B. Riley reduced their target price on Horizon Global from $12.50 to $10.50 and set a buy rating on the stock in a research report on Monday, June 25th. Finally, Bank of America lowered Horizon Global from a buy rating to an underperform rating and reduced their target price for the company from $10.00 to $5.00 in a research report on Friday, June 22nd. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and three have assigned a buy rating to the company’s stock. The stock has a consensus rating of Hold and an average target price of $13.58.
Top 5 Value Stocks For 2019: Pluristem Therapeutics Inc.(PSTI)
Advisors' Opinion:- [By Max Byerly]
Get a free copy of the Zacks research report on Pluristem Therapeutics (PSTI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Here are some of the news headlines that may have impacted Accern’s rankings:
Get Pluristem Therapeutics alerts: Pluristem Therapeutics Inc. (PSTI) Given Consensus Rating of “Buy” by Analysts (americanbankingnews.com) Head-To-Head Analysis: Pluristem Therapeutics (PSTI) & Amgen (AMGN) (americanbankingnews.com) Pre-Eclampsia Treatment Market Outlook 2025, Global Opportunity & Growth Analysis, Key Players – Alnylam … (menafn.com) Flickering Three Stocks: Golden Star Resources Ltd. (NYSE:GSS), Pluristem Therapeutics Inc. (NASDAQ:PSTI … (thestreetpoint.com) Pluristem Therapeutics Inc. (PSTI) moves -0.72% higher to SMA-50 (nasdaqplace.com)Pluristem Therapeutics stock traded up $0.01 during trading hours on Monday, reaching $1.37. The stock had a trading volume of 3,754 shares, compared to its average volume of 201,217. The firm has a market cap of $150.78 million, a PE ratio of -4.28 and a beta of 0.32. Pluristem Therapeutics has a 52 week low of $1.12 and a 52 week high of $2.12.
- [By Shane Hupp]
Get a free copy of the Zacks research report on Pluristem Therapeutics (PSTI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
Momenta Pharmaceuticals (NASDAQ: MNTA) and Pluristem Therapeutics (NASDAQ:PSTI) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.
- [By Ethan Ryder]
Shares of Pluristem Therapeutics Inc. (NASDAQ:PSTI) have earned an average recommendation of “Buy” from the seven research firms that are currently covering the stock, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $4.13.
- [By Stephan Byrd]
Pluristem Therapeutics Inc. (NASDAQ:PSTI) has been given a consensus recommendation of “Buy” by the six brokerages that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. The average 1 year target price among brokers that have covered the stock in the last year is $4.00.
Top 5 Value Stocks For 2019: Gilead Sciences, Inc.(GILD)
Advisors' Opinion:- [By Keith Speights, Chuck Saletta, and Brian Feroldi]
We asked three Motley Fool contributors to weigh in on which biotech stocks they like. Here's why they chose Celgene (NASDAQ:CELG), Exelixis (NASDAQ:EXEL), and Gilead Sciences (NASDAQ:GILD) as their top picks to buy right now.
- [By George Budwell]
Gilead Sciences (NASDAQ:GILD), a blue chip biotech stock, meets both of these critical criteria. Even so, this top biotech is rarely considered purely for its prospects as a dividend growth stock. The reason? Gilead only started doling out a dividend approximately three years ago this month. As a result, the company has yet to shed its well-earned image as a top growth stock within the broader investing community.
- [By Chris Lange]
Gilead Sciences Inc. (NASDAQ: GILD) saw its short interest decrease to 17.44 million shares from 18.22 million in the previous period. Shares were trading at $72.72, in a 52-week range of $63.76 to $89.54.
Top 5 Value Stocks For 2019: Houston Wire & Cable Company(HWCC)
Advisors' Opinion:- [By Max Byerly]
Houston Wire & Cable (NASDAQ:HWCC) hit a new 52-week high and low during mid-day trading on Wednesday after an insider bought additional shares in the company. The stock traded as low as $8.40 and last traded at $8.35, with a volume of 604 shares traded. The stock had previously closed at $7.90.
Top 5 Value Stocks For 2019: Brown-Forman Corporation (BF-A)
Advisors' Opinion:- [By Dan Caplinger]
The stock market did exceptionally well on Wednesday, with the Dow Jones Industrial Average climbing more than 300 points and certain other major benchmarks reaching record heights. In general, investors remained upbeat about the prospects for the U.S. economy overcoming any trade-related tensions and continuing to grow, riding the wave of lower corporate tax rates to boost profits. Yet even with a favorable mood in the market overall, some companies had bad news that sent their shares sharply lower. Ambarella (NASDAQ:AMBA), YY (NASDAQ:YY), and Brown-Forman (NYSE:BF-A) (NYSE:BF-B) were among the worst performers on the day. Here's why they did so poorly.
Top 5 Value Stocks For 2019: Ecolab Inc.(ECL)
Advisors' Opinion:- [By ]
3. Ecolab (NYSE: ECL)
This water, hygiene, and energy services company is being heavily bought by Bill Gates. Mr. Gates has purchased around a million shares across several transactions in the last 30 days. His purchase price was between $134.00 and $137.00 per share. - [By ]
In the Lightning Round, Cramer was bullish on Goldman Sachs (GS) , Berkshire Hathaway (BRK.B) , Ecolab (ECL) , PTC (PTC) , Arista Networks (ANET) , U.S. Concrete (USCR) and Masco (MAS) .
- [By Garrett Baldwin]
If the answer is no, then understand that you are not alone – and you need to click here now…
Stocks to Watch Today: HSBC, NAVI, LUV Shares of HSBC Holdings Plc. (NYSE: HSBC) fell more than 2% in pre-market hours. The slide came after the bank announced that it anticipated "a weaker global economic outlook." The bank also issued a warning about the upcoming Brexit and said that many of its customers in the United Kingdom are "understandably cautious about the immediate future." The firm also issued a weaker earnings report than expected. The company to watch today is Navient Corp. (NASDAQ: NAVI), which is the largest student loan servicer in the country. Sallie Mae spun off the company in 2013. It has 12 million customers and services about $300 billion in loans. While no one likes student loans, a few key metrics show this stock is a raging buy right now. Here's what you need to know to get your trading week started. Southwest Airlines Co. (NYSE: LUV) is under scrutiny from the Federal Aviation Administration. According to reports, a probe is underway on whether the company has failed to calculate checked baggage loads on flights correctly. The Wall Street Journal reports that several planes carried 1,000 pounds of cargo more than what was listed on flight paperwork. Look for earnings reports from Advance Auto Parts Inc. (NYSE: AAP), Ecolab Inc. (NYSE: ECL), La-Z-Boy Inc. (NYSE: LZB), LendingClub Corp. (NYSE: LC), and Texas Roadhouse Inc. (NASDAQ: TXRH).Follow Money Morning on Facebook, Twitter, and LinkedIn.
- [By Max Byerly]
In other news, Chairman Douglas M. Baker, Jr. sold 40,025 shares of the stock in a transaction on Wednesday, November 7th. The shares were sold at an average price of $160.20, for a total transaction of $6,412,005.00. Following the completion of the sale, the chairman now directly owns 558,017 shares in the company, valued at $89,394,323.40. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Leslie S. Biller sold 2,811 shares of the stock in a transaction on Friday, November 30th. The stock was sold at an average price of $160.40, for a total transaction of $450,884.40. Following the sale, the director now owns 57,842 shares of the company’s stock, valued at $9,277,856.80. The disclosure for this sale can be found here. Corporate insiders own 1.50% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “Ecolab (ECL) Updates Q4 Earnings Guidance” was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this story on another website, it was stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this story can be read at https://www.tickerreport.com/banking-finance/4125845/ecolab-ecl-updates-q4-earnings-guidance.html.About Ecolab
- [By Ethan Ryder]
Ecolab Inc. (NYSE:ECL) – Jefferies Financial Group dropped their Q4 2018 EPS estimates for Ecolab in a report released on Tuesday, July 31st. Jefferies Financial Group analyst L. Alexander now anticipates that the basic materials company will post earnings per share of $1.73 for the quarter, down from their prior forecast of $1.74.
- [By Scott Levine]
Here are three starkly different opportunities -- Aqua America (NYSE:WTR), Franco-Nevada Corp. (NYSE:FNV), and Ecolab (NYSE:ECL) -- that could help investors avoid tossing and turning all night.
No comments:
Post a Comment